NCT03053700

Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea

Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea- a Prospective Study

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Rabin Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is an interventional and prospective study. The study is designed to evaluate the additional benefits of a combination of IPL treatment and local application of Bromonide 0.33% gel in the treatment of erythematotelangiectatic (ETR) and papulopustular (PPR).

Detailed description

Patients would be treated with full face application of bromonide 0.33% gel once daily for three months. In addition half of the patients' face would be subjected to three IPL treatment sessions three weeks apart from each other.

Conditions

• Rosacea

Interventions

Type	Name	Description
DRUG	Bromonide 0.33% gel	Patients would be treated with full face application of bromonide 0.33% gel once daily for three months.
DEVICE	Intense Pulsed Light (M22)	Half of the patients' face would be subjected to three IPL treatment sessions three weeks apart from each other.

Timeline

• Start date: 2018-12-01
• Primary completion: 2019-01-02
• Completion: 2019-01-02
• First posted: 2017-02-15
• Last updated: 2022-10-31

Locations

1 site across 1 country: Israel